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In the present study, a series of novel thiazolo quinazoline derivatives were 
synthesized by condensation of different aromatic aldehydes with 4-nitro aniline. The 
chemical structures of the synthesized compounds were confirmed by means of IR, 1H-NMR, 
mass spectroscopy and elemental analyses. These compounds were screened for anti-oxidant 
activity by DPPH radical assay, nitric oxide scavenging activity and Hydrogen Peroxide 
scavenging activity. Among the synthesized compounds 5d, 5c and 5b was found to be the 
most potent anti-oxidant activity.  
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Abbreviations:  (DPPH) 1, 1-diphenyl-2-picryl-hydrazyl, (DMF) Dimethyl formamide, (NO) 
Nitric oxide, (ROS) Reactive oxygen species. 
 
 
Free radicals are chemical species 
containing one or more unpaired electrons, 
most of them being unstable and capable of 
abstracting electrons from other molecules. 
The predominant reactive oxygen species  
and reactive nitrogen intermediates 
generated by cell metabolism or by 
exogenous factors include hydrogen peroxide 
(.H2O2), the hydroxyl radical (.OH), the 
superoxide anion radical .(-O2), nitric oxide 
•(NO) and peroxynitrite •(ONOO-).  Oxygen 
is critical for life on earth. It is produced by 
plants during photosynthesis, and is 
necessary for aerobic respiration for animals. 
In the last few decades, research on free 
radicals gained more importance (Halliwell, 
2008, Sachdev et al., 2008, Kamat et al., 2006). 
Oxygen and nitrogen derived free radicals 
are generated during cellular metabolism and 
mitochondrial energy production. The 
oxygen consumption inherent in cell growth 
leads to the generation of series of reactive 
oxygen species (ROS). ROS are continuously 
produced by the body’s normal oxygen usage 
such as respiration and some cell mediated 
immune functions. ROS such as hydroxyl 
ions, superoxide anions, and peroxyl radicals, 
are involved in oxidative damage to cell 
components (Gulcin, 2006). ROS may be 
required for normal cell function at 
physiological concentrations. The 
consequence of an imbalance of prooxidants 
and anti-oxidants in the organism, if ROS are 
not effectively scavenged by cellular 
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constituents, they can stimulate free radical 
chain reactions subsequently damaging the 
cellular biomolecules such as proteins, lipids 
and nucleic acids, and finally gaining 
recognition as a key phenomenon in chronic 
illnesses (Halliwell et al., 1990; Gulcin et al., 
2003). Therefore the discovery of new safer 
anti-oxidant drugs becomes essential. Several 
quinazolines and condensed quinazolines 
derivatives have associated with a broad 
range of physiological activities, exhibiting 
anti-oxidant, analgesic, anti-inflammatory 
and anti-convulsant (Michael et al., 2008; 
Natalia et al., 2007; El-Gazzar et al., 2009; 
Alagarsamy et al., 2003; 2006). On the other 
hand, some thiazole derivatives also have 
various biological properties like anti-oxidant 
(Feng Shi et al., 2009; Charles et al., 2007; 
Athina et al., 2008; Hong et al., 2007), anti-
inflammatory (Tajana et al., 1979), anti-
microbial (Shukla et al., 1989), anthelmintic 
(Malesic, 1997) and immunorestoration 
(McDonald, 1992). Based on prior 
observations we synthesized a series of 
compounds (5a-5f) containing thiazolo 
quinazoline which could be effective for 
antioxidant activity. 
 
Materials and Methods 
1,-1-Diphenyl-2-picryl-hydrazine 
(DPPH) was purchased from Sigma-Aldrich 
(St. Louis, USA). Ascorbic acid and methanol 
were purchased from E. Merck (Darmstadt, 
Germany). The remaining solvents and other 
chemicals were of purchased from Sigma-
Aldrich (St. Louis, USA). The melting points 
were taken in open capillary tube and are 
uncorrected. IR spectra were recorded with 
KBr pellets (ABB Bomem FT-IR spectrometer 
MB 104 ABB Limited, Bangaluru, India). 
Proton (1H) NMR spectra (Bruker 400 NMR 
spectrometer Mumbai, India) were recorded 
with TMS as internal references. Mass 
spectral data were recorded with a quadrupol 
mass spectrometer (Shimadzu GC MS QP 
5000, Chennai, India), and microanalyses 
were performed using a vario 
EL V300 elemental analyzer (Elemental  
Analysensysteme GmbH Chennai, India). The 
purity of the compounds was checked by 
TLC on pre-coated SiO2 gel (HF254, 200 mesh) 
aluminium plates (E. Merck) using ethyl 
acetate: benzene (1 : 3) and visualized in UV 
chamber. IR, 1H-NMR, mass spectral datas 
and elemental analysis were consistent with 
the assigned structures. 
 
Chemistry 
The synthetic strategy leading to the key 
intermediate and the target compounds are 
illustrated in Scheme 2. 6,7,8,9 tetra hydro-
5H-5-(2'-hydroxy phenyl) thiazolo (2, 3-b) 
quinazolin-3(2H)-one 3 prepared by the 
equimolar quantities of each (0.039 mol) of 
cyclohexanone and salicylaldehyde (0.039 
mol) were taken in a beaker, to this sodium 
hydroxide solution was added to make the 
solution alkaline, this was shaken and kept 
aside. The solid thus obtained, was filtered, 
washed with water and recrystallized from 
absolute ethanol. A mixture of 2-hydroxy 
benzylidine cyclohexanone ring 1 (0.039 mol) 
thiourea (0.03 mol) and potassium hydroxide 
(2.5g) in ethanol (100 mL) was heated under 
reflux for 3h. The reaction mixture was 
concentrated to half of its volume, dilute with 
water, then acidified with dilute acetic acid 
and kept overnight. The solid thus obtained, 
was filtered, washed with water and 
recrystallized from ethanol to give 4-hydroxy 
phenyl 3, 4, 5, 6, 7, 8-hexahydro quinazolin-2-
thione 2. The chloroacetic acid (0.096 mol) 
was melted on a water bath and thione (0.009 
mol) added to it portion wise to maintain its 
homogeneity. The homogeneous mixture was 
further heated on a water bath for 30 min and 
kept overnight. The solid thus obtained was 
washed with water until neutralized and 
crystallized from ethanol to give 6,7,8,9 tetra 
hydro-5H-5-(2'-hydroxy phenyl) thiazolo (2, 
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3-b) quinazolin-3(2H)-one 3 (Sharma et al., 
1991). A mixture of 3 (0.002 mol), substituted 
benzaldehyde (0.002 mol) and anhydrous 
sodium acetate (0.2g 0.002 mol) in glacial 
acetic acid (10 mL) was heated under reflux 
for 4h. The reaction mixture was kept 
overnight and the solid, thus separated, was 
filtered, washed with water and 
recrystallized from ethanol to furnish of 
6,7,8,9 tetra hydro-5H-5-(2'-hydroxy phenyl)-
2-(4'-substituted benzylidine) thiazolo (2,3-b) 
quinazolin-3(2H)-one 4. Equimolar quantities 
(0.004 mol) of compound 4 treated with  
thionyl chloride and DMF to get chloro 
derivative  and then coupled with p-nitro 
anilines in DMF at 800C and quenched in ice-
water to get the product were separated by 
filtration, vaccum dried and recrystallized 
from warm ethanol to yields 6,7,8,9 tetra 
hydro-5H-5-(2'-hydroxy phenyl)-2-(4'- 
substituted benzylidine)-3-(4-nitrophenyl 
amino) thiazolo quinazoline (5a-5f) Scheme 
2. The spectral data IR, 1H NMR, mass 
spectroscopy and elemental analyses were 
used to ascertain the structures of all the 
compounds. 
1H NMR spectra were recorded for all the 
target compounds. The 1H NMR spectra were 
recorded for the representative key 
intermediate 3. The 6,7,8,9 tetra hydro-5H-5-
(2-hydroxy phenyl) thiazoloquinazolin-3-one. 
Yield: 71%; m.p.153-155 °C; IR (KBr, cm-1): 
3402 (phenolic OH), 3046 (Ar-CH), 1719 
(C=O), 1462 (C=C) cm-1; 1H-NMR (CDCl3) δ: 
6.61-6.89 (m,4H Ar-H), 5.71 (s, 1H; -CH) 9.91 
(s, 1H; Ar-OH), 3.76 (s, 2H; -CH2) 1.6-2.42 (m, 
8H; CH2, CH2, CH2, CH2 ).EI-MS m/z (M+): 
300 (Calcd for C16H16N2O2S; 300.38). Anal. 
Calcd for C16H16N2O2S; C, 63.98; H, 5.37; N, 
9.32; Found: C, 63.92; H, 5.28; N, 9.30.  
6,7,8,9 tetra hydro-5H-5-(2'-hydroxy phenyl)-2-
benzylidine thiazolo (2, 3-b) quinazolin-3(2H)-one 
(4) 
Yellow solid; Yield: 82%; mp. 153-155 °C; IR : 
3450 (O-H), 3051 (Ar-CH), 1724 (C=O), 1472 
(C=C) cm-1. 1H-NMR (CDCl3): δ 6.92-7.56 (m, 
9H, Ar-H), 6.63 (s, 1H, =CH), 5.81 (s, 1H, H-
5), 9.74 (s, 1H, Ar-OH), 1.58-2.67 (m, 8H, 4 × 
CH2); EI-MS (m/z): 377 (M+); (Calcd for 
C23H20N2O2S; 377.48). Anal. Calcd for 
C23H20N2O2S, C, 71.11; H, 5.19; N, 7.21; Found: 
C, 71.19; H, 5.26; N, 7.14. 
6,7,8,9 tetra hydro-5H-5-(2'-hydroxy phenyl)-2-
benzylidine-3-(4-nitrophenyl amino) thiazolo 
quinazoline (5a) 
Pale solid; Yield: 78%; mp. 157-159 °C IR : 
3461 (O-H), 3029 (Ar-CH), 1492 (C=C), 1316 
(N-H bending), 3391 (N-H stretching) cm-1; 
1H-NMR (CDCl3): δ 6.74-7.13 (m, 13H, Ar-H), 
6.32 (s, 1H, =CH),5.59 (s, 1H, H-5), 9.81 (s, 1H, 
Ar-OH), 4.42 (s, 1H, thiazole), 7.26 (s, 1H, N-
H),  1.46-2.42 (m, 8H, 4 × CH2); EI-MS (m/z): 
510 (M+); (Calcd for C29H26N4O3S; 510.61). 
Anal. Calcd for C29H26N4O3S; C, 68.21; H, 5.13; 
N, 10.97; Found: C, 68.26; H, 5.19; N, 10.82. 
6,7,8,9 tetra hydro-5H-5-(2'-hydroxy phenyl)-2-
(4'-hydroxybenzylidine)-3-(4-nitrophenyl amino) 
thiazolo quinazoline (5b) 
Pale yellow solid; Yield: 72%; mp. 151-153 °C 
IR : 3467 (O-H), 3021 (Ar-CH), 1497 (C=C), 
1312 (N-H bending), 3391 (N-H stretching) 
cm-1; 1H-NMR (CDCl3): δ 6.74-7.29 (m, 12H, 
Ar-H), 6.36 (s, 1H, =CH),5.62 (s, 1H, H-5), 9.87 
(s, 2H, Ar-OH), 4.46 (s, 1H, thiazole),  7.42 (s, 
1H, N-H), 1.46-2.42 (m, 8H, 4 × CH2); EI-MS 
(m/z): 556 (M+); (Calcd for C30H26N4O5S; 
556.63). Anal. Calcd for C30H26N4O5S; C, 64.73; 
H, 5.07; N, 10.07; Found: C, 64.79; H, 5.11; N, 
10.12. 
6,7,8,9 tetra hydro-5H-5-(2'-hydroxy phenyl)-2-
(4'-hydroxy-5'-methoxy benzylidine)-3-(4-
nitrophenyl amino) thiazolo quinazoline (5c) 
Pale yellow solid; Yield: 76%; mp. 156-158 °C 
IR : 3464 (O-H), 3027 (Ar-CH), 1494 (C=C), 
1306 (N-H bending), 3396 (N-H stretching) 
cm-1; 1H-NMR (CDCl3): δ 6.72-7.23 (m, 12H, 
Ar-H), 6.36 (s, 1H, =CH),5.62 (s, 1H, H-5), 9.89 
(s, 1H, Ar-OH), 4.46 (s, 1H, thiazole),  3.78 (s, 
3H –OCH3), 7.29 (s, 1H, N-H),  1.46-2.42 (m, 
8H, 4 × CH2); EI-MS (m/z): 540 (M+); (Calcd 
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for C30H28N4O4S; 540.18). Anal. Calcd for 
C30H28N4O4S; C, 66.65; H, 5.22; N, 10.36; 
Found: C, 66.67; H, 5.25; N, 10.38. 
6,7,8,9 tetra hydro-5H-5-(2'-hydroxy phenyl)-2-
(3', 4', 5'-tri methoxy benzylidine)-3-(4-
nitrophenyl amino) thiazolo quinazoline (5d) 
Cream solid; Yield: 71%; mp. 187-189 °C IR : 
3429 (O-H), 3027 (Ar-CH), 1413 (C=C), 1334 
(N-H bending), 3313 (N-H stretching) cm-1; 
1H-NMR (CDCl3): δ 6.72-7.21 (m, 10H, Ar-H), 
6.27 (s, 1H, =CH), 5.72 (s, 1H, H-5), 9.91 (s, 
1H, Ar-OH), 4.42 (s, 1H, thiazole), 3.32 (s, 
9H,–OCH3), 7.47 (s, 1H, N-H),  1.34-2.46 (m, 
8H, 4 × CH2); EI-MS (m/z): 600 (M+); (Calcd 
for C32H32N4O6S; 600.68). Anal. Calcd for 
C32H32N4O6S; C, 63.98; H, 5.37; N, 9.33; Found: 
C, 63.81; H, 5.39; N, 9.37. 
6,7,8,9 tetra hydro-5H-5-(2'-hydroxy phenyl)-2-
(5'-nitro benzylidine)-3-(4-nitrophenyl amino) 
thiazolo quinazoline (5e) 
Yellow solid; Yield: 79%; mp. 154-156 °C IR : 
3467 (O-H), 3026 (Ar-CH), 1486 (C=C), 1311 
(N-H bending), 3397 (N-H stretching) cm-1; 
1H-NMR (CDCl3): δ 6.77-7.23 (m, 12H, Ar-H), 
6.24 (s, 1H, =CH), 5.69 (s, 1H, H-5), 9.89 (s, 
1H, Ar-OH), 4.42 (s, 1H, thiazole), 7.23 (s, 1H, 
N-H), 1.41-2.46 (m, 8H, 4 × CH2); EI-MS 
(m/z): 555 (M+); (Calcd for C29H25N5O5S; 
555.6). Anal. Calcd for C29H25N5O5S; C, 62.69; 
H, 4.54; N, 12.60; Found: C, 62.54; H, 4.49; N, 
12.59. 
6,7,8,9 tetra hydro-5H-5-(2'-hydroxy phenyl)-2-
(4'-nitro benzylidine)-3-(4-nitrophenyl amino) 
thiazolo quinazoline (5f) 
Pale yellow solid; Yield: 71%; mp. 152-154 °C 
IR : 3461 (O-H), 3021 (Ar-CH), 1493 (C=C), 
1309 (N-H bending), 3392 (N-H stretching) 
cm-1; 1H-NMR (CDCl3): δ 6.73-7.21 (m, 12H, 
Ar-H), 6.33 (s, 1H, =CH), 5.67 (s, 1H, H-5), 
9.81 (s, 1H, Ar-OH), 4.46 (s, 1H, thiazole), 7.19 
(s, 1H, N-H), 1.46-2.42 (m, 8H, 4 × CH2); EI-
MS (m/z): 555 (M+); (Calcd for C29H25N5O5S; 
555.6). Anal. Calcd for C29H25N5O5S; C, 62.69; 
H, 4.54; N, 12.60; Found: C, 62.62; H, 4.51; N, 
12.67. 
Antioxidant Screening 
DPPH radical scavenging activity 
DPPH solution, 1 mmol/L, was prepared by 
dissolving 31.54 mg DPPH in 95% v/v 
buffered methanol (40 mL of 0.1 mol/L 
acetate buffer (pH 5.5) with 60 mL of 
methanol) and made up to 50 mL with 
buffered methanol. DPPH scavenging activity 
was assessed using the method of (Hatano et 
al., 1988; Gow Chin et al., 1995).  The 
synthesized compounds (5a-5f) at different 
concentrations such as 0.2, 0.4, 0.6, 0.8, 1.0 mL 
(200, 400, 600, 800 and 1000 µg/mL) were 
made up to 4 mL with distilled water. 1 mL of 
DPPH (1 mmol, 3.953×10-10 µg/mL) was 
added to each test tube, shaken and the 
reaction mixture was kept at 300 C for 30 
minutes. Absorbance of the resulting solution 
was measured spectrophotometrically at 517 
nm. The effect of ascorbic acid (vitamin C) on 
DPPH was also assessed for comparison with 
that of synthesized compounds (5a-5f). A 
buffered methanolic dilution (0.2, 0.4, 0.6, 0.8, 
1.0 mL) of 1 mg/mL ascorbic acid was made 
to 4 mL with distilled water. 1mL DPPH 
radical (1 nmol/L) was added to each tube 
and same procedure as in DPPH scavenging 
experiment was followed. The absorbance 
measured for the control solution (Buffered 
methanol with DPPH) was in the range 0.500 
± 0.040 (Sharma et al., 2009). Antiradical 
activity was expressed as inhibition 
percentage (I %) and calculated using the 
following equation: 
Inhibition Percentage = [(Absorbance control – 
Absorbance sample)/ Absorbance control] × 100  
 
 Nitric oxide scavenging activity 
Nitric oxide scavenging activity was measured 
spectrophotometrically (Govindarajan et al., 
2003). The reaction mixture (3 mL) containing 2 
mL of an aqueous solution of sodium 
nitroprusside (5 mmol/L), 0.5 mL phosphate 
buffer saline as a good solvent for DPPH, and 
different concentrations (200 µg/mL-1000 µg/ 
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mL, 0.5 mL) of the synthetic compounds (5a-
5f)  or the standard solution (rutin, 0.5 mL) 
were incubated at 25°C for 30 minutes. A 
control without the test compound, but with 
an equivalent amount of buffered methanol, 
was taken. After 30 min, 1.5 mL of the 
incubated solution was removed and diluted 
with 1.5 mL Griess reagent (1% 
sulphanilamide, 2% phosphoric acid and 0.1% 
N-1-naphthylethylenediamine dihydro 
chloride). Absorbance of the chromophore 
formed during diazotization of the 
sulphanilamide with nitrite and subsequent 
coupling with N-1-naphthylethylene diamine 
dihydrochloride was measured at 546 nm and 
the percentage scavenging activity was 
measured with reference to the standard. 
 
Hydrogen Peroxide scavenging activity 
The ability of test compounds to scavenge 
hydrogen peroxide was determined according 
(Sanchez, 2001; Famey et al., 1998). The solution 
of hydrogen peroxide (20 mmol) was prepared 
in phosphate buffer saline (pH 7.4). 1 mL of 
various concentrations (200 µg/mL-1000 
µg/mL) of test compounds and standard were 
added to 2 mL of hydrogen peroxide. 
Absorbance of hydrogen peroxide at 230 nm 
was determined 10 min later against a blank 
solution containing the phosphate buffer saline 
without hydrogen peroxide. H2O2 radical 
scavenging ability of test and standard 
compounds (vitamin E) was calculated by 
%Scavenged [H2O2] = [(Absorbance control - 
Absorbance sample)/ Absorbance control] × 100 
 
Results and Discussion 
Chemistry 
The synthesized series of heterocycles, 
4 and 5a-5f by the reaction of 3 with 
appropriate aromatic aldehydes and p –nitro 
aniline in the presence of anhydrous sodium 
acetate and DMF as presented in Scheme 1. 
The IR, 1H-NMR, mass spectroscopy and 
elemental analysis for the new compound is 
in accordance with the assigned structures. 
The IR spectra of compounds 4 showed 
stretching bands of keto group at 1715-1740 
cm-1. In 5a-5f, stretching and bending NH 
bands of thiazolo quinazoline moiety appear 
at 3300-3400 cm-1, 1300-1350 cm-1 respectively. 
The recorded IR spectra of representative 
compounds 5a-5f showed missing of keto 
group bands. This clearly envisages that the 
keto group of 4 is converted in to secondary 
NH. The proton magnetic resonance spectra 
of thiazolo quinazoline and their 
corresponding derivatives have been 
recorded in CDCl3. In this 5a-5f NH signal of 
3-(4-nitro phenyl) amino thiazolo quinazoline 
moiety appear at 7.19-7.67 (s) ppm 
respectively. The position and presence of 
NH signal in the 1H-NMR spectra of final 
compounds conforms the secondary NH 
proton in thiazolo quinazoline moiety. This 
clearly envisages that thiazole-3-one moiety 
involve in 3-(4-nitro phenyl) amino 
formation. All these observed facts clearly 
demonstrate that 3rd position of keto group in 
thiazole ring is converted in to secondary 
amino group as indicated in scheme 2 and 
conforms the proposed structure (5a -5f). 
 
Anti-oxidant Testing 
Compounds 5a-5f was tested for anti-oxidant 
property by DPPH, nitric oxide and 
Hydrogen Peroxide scavenging methods. The 
observed data of the anti-oxidant activity is 
given in Figure 1-3. 
 
DPPH radical scavenging is considered a 
good in vitro model and is widely used to 
conveniently assess antioxidant efficacy. In its 
radical form, DPPH has an absorbance at 515 
nm which disappears when DPPH is reduced 
by an antioxidant compound or a radical 
species to become a stable diamagnetic 
molecule. As a result, the color changes from 
purple to yellow. This color change is taken 
as an indication of the hydrogen
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Figure 1. Scavenging effect of synthesized compounds (5a-5f) and standard vitamin C on 1, -1’-
diphenyl-2-picryl hydrazyl (DPPH) radical. Results are the means ± S.D of five parallel 
measurements. 
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Figure 2. Effect of synthesized compounds (5a-5f) and vitamin E on hydrogen peroxide 
scavenging activity. Results are the means ± S.D of five parallel measurements 
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Nitric oxide scavenging activity
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Figure 3 Scavenging effect of synthesized compounds (5a-5f) and standard rutin on nitric oxide 
radical. Results are the means ± S.D of five parallel measurements 
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donating ability of the tested compounds.  
Antioxidants can react with DPPH and 
produce 1, 1-diphenyl-2-picryl-hydrazine 
Scheme 1 (Blois, 1958). The antioxidant 
activity of thiazoloquinazoline in general can 
be explained due to the presence of 
substituted aromatic aldehyde groups at the 
second position of thiazole ring. The reducing 
abilities of the examined compounds were 
determined by their interaction with the free 
stable radical 1,-1-diphenyl-2-picryl-
hydrazine (DPPH) at five different 
concentrations for 30 min. The highest 
scavenger activity observed in compound 5d 
is probably due to the presence of methoxy 
groups at positions 3, 4 and 5 in aromatic ring 
(Figure 1). The better activity of compound 5c 
having hydroxyl group at p- position in the 
aromatic ring, has high electron-releasing 
properties (positive mesomeric effect is 
higher than negative inductive effect) and it 
activates aromatic ring. The same is valid for 
5b also. Generally, carboxyl and nitro groups 
are electron-withdrawing substituents which, 
deactivate the aromatic ring and have no 
capability to bind free radicals. The better 
scavenger activity of 5e in comparison with 5f 
is probably due to the lower electron-
withdrawing effect of m-nitro group than that 
of p-nitro group. This could be the 
explanation of the good antioxidative activity 
of 5d and 5c and of the lower activity of 5f. 
The cellular toxicity of nitric oxide has been 
associated with its reaction derivatives, 
especially peroxynitrite which could lead to 
DNA fragmentation and protein 
modification. Thus, nitric oxide scavengers 
could lower the risk of cellular and tissue 
damages associated with excessive nitric 
oxide production. The in vitro scavenging 
activities of the compound 5f against nitric 
oxide at 1000 µg/mL was weak due to the 
electron withdrawing group (-NO2). The 
remaining compounds having electron 
donating groups like 5d, 5c and 5b showed 
better scavenging activity against nitric 
oxide free radicals at the same 
concentration, compared to the standard 
drug rutin (Figure 3). All the synthesized 
compounds evaluated in this study exhibited 
concentration–dependent inhibition of 
hydrogen peroxide activity, which was also 
dependent on electron releasing nature of the 
compounds (Figure 2). The compound 5d 
potently inhibited hydrogen peroxide activity 
at low concentration. Moreover the 
compounds 5c and 5b also inhibited 
hydrogen peroxide activity for the same 
reason. The weakest inhibitory activity was 
observed for the compounds 5f and 5e due to 
electron withdrawing nature of the 
substituent. 
 
Conclusion 
Several new thiazolo quinazolines 
were synthesized in moderate to good 
yield. The antioxidant properties of these 
molecules were evaluated by three methods. 
The prominent antioxidant effectiveness of 
the studied compounds seems to be related to 
the presence of electron donating group 
substituents in the aromatic rings. In the 
future, further studies with different 
substituents will be performed. 
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